3,322
Views
30
CrossRef citations to date
0
Altmetric
Research Paper

Parents’ hesitation about getting their children vaccinated against COVID-19 in Japan

ORCID Icon &
Pages 4993-4998 | Received 13 Jul 2021, Accepted 10 Sep 2021, Published online: 08 Oct 2021

References

  • Centers for Disease Control and Prevention (CDC).Ten great public health achievements–United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48:241–43.
  • Jacobson RM, St Sauver JL, Finney Rutten LJ. Vaccine hesitancy. Mayo Clin Proc. 2015;90:1562–68. doi:10.1016/j.mayocp.2015.09.006.
  • Kennedy A, Lavail K, Nowak G, Basket M, Landry S. Confidence about vaccines in the United States: understanding parents’ perceptions. Health Aff (Millwood). 2011;30:1151–59. doi:10.1377/hlthaff.2011.0396.
  • Wu AC, Wisler-Sher DJ, Griswold K, Colson E, Shapiro ED, Holmboe ES, Benin AL. Postpartum mothers’ attitudes, knowledge, and trust regarding vaccination. Matern Child Health J. 2008;12:766–73. doi:10.1007/s10995-007-0302-4.
  • Casiday R, Cresswell T, Wilson D, Panter-Brick C. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine. 2006;24:177–84. doi:10.1016/j.vaccine.2005.07.063.
  • Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21:977–82. doi:10.1007/s10198-020-01208-6.
  • Yoda T, Katsuyama H. Willingness to receive COVID-19 vaccination in Japan. Vaccines. 2021;9:48. doi:10.3390/vaccines9010048.
  • Takahashi R, Sugiyama S, Osaki T. Workplace and university vaccinations ramp up in Japan. Tokyo (Japan): Japan Times; 2021 June 21 [accessed 2021 July 1]. https://www.japantimes.co.jp/news/2021/06/21/national/vaccination-drive-pace/.
  • Wallace M, Woodworth KR, Gargano JW, Scobie HM, Blain AE, Moulia D, Chamberland M, Reisman N, Hadler SC, MacNeil JR, et al. The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 years - United States, May 2021. MMWR Morb Mortal Wkly Rep. 2021;70:749–52. doi:10.15585/mmwr.mm7020e1.
  • Plotkin SA, Levy O. Considering mandatory vaccination of children for COVID-19. Pediatrics. 2021;147(6):e2021050531. doi:10.1542/peds.2021-050531.
  • Mintz K, Jardas E, Shah S, Grady C, Danis M, Wendler D. Enrolling minors in COVID-19 vaccine trials. Pediatrics. 2021;147(3):e2020040717. doi:10.1542/peds.2020-040717.
  • Hamed T. Determining sample size; how to calculate survey sample size. Int J Econ Manage Syst. 2017;2:237–39.
  • Bartlett JE, Kotrlik J, Higgins C. Organizational research: determining appropriate sample size in survey research. Inform Technol Learn Perform J. 2001;19:43–50.
  • Bell S, Clarke R, Mounier-Jack S, Walker JL, Paterson P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England. Vaccine. 2020;38:7789–98. doi:10.1016/j.vaccine.2020.10.027.
  • Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–15. doi:10.1056/NEJMoa2034577.
  • Walsh EE, Frenck RW Jr., Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, et al. Safety and immunogenicity of two RNA-Based Covid-19 vaccine candidates. N Engl J Med. 2020;383:2439–50. doi:10.1056/NEJMoa2027906.
  • Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25:1663–69.
  • Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021. Jama. 2021;325:1101–02. doi:10.1001/jama.2021.1967.
  • Caminati M, Guarnieri G, Senna G. Who is really at risk for anaphylaxis due to COVID-19 vaccine? Vaccines. 2021;9:38. doi:10.3390/vaccines9010038.
  • Center for Diseases Control and Prevention. Interim considerations: preparing for the potential management of anaphylaxis after COVID-19 vaccination. Washington (DC): Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs; 2021 Feb 26 [accessed 2021 July 1]. https://www.cdc.gov/vaccines/covid-19/downloads/IntermConsid-Anaphylaxis-covid19-vaccine-sites.pdf.
  • Banerji A, Wickner PG, Saff R, Stone CA Jr., Robinson LB, Long AA, Wolfson AR, Williams P, Khan DA, Phillips E, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol Pract. 2021;9:1423–37. doi:10.1016/j.jaip.2020.12.047.
  • Centers for Disease Control and Prevention (CDC) Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14- 23,2020. MMWR Morb Mortal Wkly Rep. 2021;70:46–51. doi:10.15585/mmwr.mm7002e1.
  • Abu Mouch S, Roguin A, Hellou E, Ishai A, Shoshan U, Mahamid L, Zoabi M, Aisman M, Goldschmid N, Berar Yanay N, et al. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021;39:3790–93. doi:10.1016/j.vaccine.2021.05.087.
  • Kim HW, Jenista ER, Wendell DC, Azevedo CF, Campbell MJ, Darty SN, Parker MA, Kim RJ. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021. doi:10.1001/jamacardio.2021.2828.
  • Wise J. Covid-19: should we be worried about reports of myocarditis and pericarditis after mRNA vaccines? BMJ. 2021;373:n1635. doi:10.1136/bmj.n1635.
  • Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner L, Petit A, Lewandowsky S, Vanderslott S, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2020;1–15. doi:10.1017/S0033291720005188.
  • Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16: 2204–14. doi:10.1080/21645515.2020.1790279.
  • The Lancet Infectious D. Should we vaccinate children against SARS-CoV-2? Lancet Infect Dis. 2021;21:889. doi:10.1016/S1473-3099(21)00339-X.
  • Obaro S. COVID-19 herd immunity by immunisation: are children in the herd? Lancet Infect Dis. 2021;21:758–59. doi:10.1016/S1473-3099(21)00212-7.
  • Opel DJ, Diekema DS, Ross LF. Should we mandate a COVID-19 vaccine for children? JAMA Pediatr. 2021;175:125–26. doi:10.1001/jamapediatrics.2020.3019.
  • Anderson EJ, Campbell JD, Creech CB, Frenck R, Kamidani S, Munoz FM, Nachman S, Spearman P. Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral? Clin Infect Dis. 2021;73:336-40. doi:10.1093/cid/ciaa1425. .
  • Kamidani S, Rostad CA, Anderson EJ. COVID-19 vaccine development: a pediatric perspective. Curr Opin Pediatr. 2021;33:144–51. doi:10.1097/MOP.0000000000000978.
  • Catma S, Reindl D. Parents' willingness to pay for a COVID-19 vaccine for themselves and their children in the United States. Hum Vaccin Immunother. 2021;17:2919–25. doi: 10.1080/21645515.2021.1919453. .
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161–64. doi:10.1016/j.vaccine.2015.04.036.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.